Skip to main content
. 2020 Aug 13;5(11):2032–2041. doi: 10.1016/j.ekir.2020.08.003

Table 2.

Treatment-emergent adverse events that occurred at least twice in the total safety population of substudy 1

Adverse events (preferred term) Patient 1 Patient 2 Patient 3 Patient 4
Fatigue
Upper respiratory tract infection
Headache
Alopecia